Melanoma vaccines: breakthrough or bust?
Cancer Invest
.
2002;20(7-8):1114-6.
doi: 10.1081/cnv-120005930.
Authors
Michael S Sabel
,
Vernon K Sondak
PMID:
12449744
DOI:
10.1081/cnv-120005930
No abstract available
Publication types
Comment
Editorial
MeSH terms
Antigens, Neoplasm / immunology*
Cancer Vaccines / therapeutic use*
Humans
Melanoma / immunology
Melanoma / therapy*
Skin Neoplasms / immunology
Skin Neoplasms / therapy*
Substances
Antigens, Neoplasm
Cancer Vaccines